Schlepckow, K.* ; Kleinberger, G.* ; Fukumori, A.* ; Feederle, R. ; Lichtenthaler, S.F.* ; Steiner, H.* ; Haass, C.*
An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function.
EMBO Mol. Med. 9, 1356-1365 (2017)
Sequence variations occurring in the gene encoding the triggering receptor expressed on myeloid cells 2 (TREM2) support an essential function of microglia and innate immunity in the pathogenesis of Alzheimer's disease (AD) and other neurodegenerative disorders. TREM2 matures within the secretory pathway, and its ectodomain is shed on the plasma membrane. Missense mutations in the immunoglobulin (Ig)-like domain such as p.T66M and p.Y38C retain TREM2 within the endoplasmic reticulum and reduce shedding as well as TREM2-dependent phagocytosis. Using mass spectrometry, we have now determined the cleavage site of TREM2. TREM2 is shed by proteases of the ADAM (a disintegrin and metalloproteinase domain containing protein) family C-terminal to histidine 157, a position where an AD-associated coding variant has been discovered (p.H157Y) in the Han Chinese population. Opposite to the characterized mutations within the Ig-like domain, such as p.T66M and p.Y38C, the p.H157Y variant within the stalk region leads to enhanced shedding of TREM2. Elevated ectodomain shedding reduces cell surface full-length TREM2 and lowers TREM2-dependent phagocytosis. Therefore, two seemingly opposite cellular effects of TREM2 variants, namely reduced versus enhanced shedding, result in similar phenotypic outcomes by reducing cell surface TREM2.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Alzheimer's Disease ; Neurodegeneration ; Phagocytosis ; Regulated Intramembrane Proteolysis ; Trem2; Amyloid Precursor Protein; Myeloid Cells-2 Trem2; Fluid Soluble Trem2; Gamma-secretase; Intramembrane Proteolysis; Microglial Response; Apolipoprotein-e; Golgi-apparatus; Beta-protein; Disease
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2017
Prepublished im Jahr
HGF-Berichtsjahr
2017
ISSN (print) / ISBN
1757-4676
e-ISSN
1757-4684
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 9,
Heft: 10,
Seiten: 1356-1365
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
Wiley
Verlagsort
Chichester
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
Institut(e)
CF Monoclonal Antibodies (CF-MAB)
POF Topic(s)
30201 - Metabolic Health
Forschungsfeld(er)
Helmholtz Diabetes Center
PSP-Element(e)
G-502210-001
Förderungen
Copyright
Erfassungsdatum
2017-10-24